Location History:
- Birmingham, AL (US) (2013)
- Chevey Chase, MD (US) (2015)
Company Filing History:
Years Active: 2013-2015
Title: The Innovations of Peter Mannon
Introduction
Peter Mannon is a distinguished inventor based in Chevy Chase, MD (US). He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory bowel diseases. With a total of 2 patents, Mannon has developed innovative methods that aim to improve patient outcomes.
Latest Patents
Mannon's latest patents include groundbreaking methods for treating and preventing inflammatory bowel disease. One of his notable inventions is a method that involves the use of IL-13 and NKT cells to address the inflammatory response associated with ulcerative colitis and Crohn's disease. This method comprises administering an effective amount of a substance that inhibits the binding of IL-13 to IL-13 receptors on NKT cells or delivers an effector molecule to these cells. Another significant patent focuses on the use of muramyl dipeptide (MDP) for treating inflammation. This invention provides a method for administering an effective amount of MDP to prevent or treat inflammation in a subject.
Career Highlights
Peter Mannon is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to explore innovative solutions to complex medical challenges.
Collaborations
Mannon has collaborated with esteemed colleagues such as Warren Strober and Ivan J Fuss. These partnerships have further enhanced his research and contributed to the advancement of medical science.
Conclusion
Peter Mannon is a prominent inventor whose work in the field of inflammatory bowel disease has the potential to transform treatment approaches. His innovative patents reflect a commitment to improving health outcomes for patients suffering from these challenging conditions.